Bioventus Inc. (BVS) Market Cap & Valuation Ratios
Bioventus Inc. (BVS) has a market cap of $1.3B and a price-to-sales ratio of 2.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BVSBioventus Inc.Follow BVS — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| BVS | 1.3 | — | 2.5 | 14.3 | 7.5% | +3% | 10% | 10% |
| CNMD | 1.5 | 26.6 | 1.7 | 14.0 | 9.1% | +3% | 8% | 4% |
| ENOV | 1.2 | — | 1.1 | 8.1 | 5.2% | +5% | -45% | -31% |
| TNDM | 1.2 | — | 1.3 | — | -2.2% | +4% | -4% | -9% |
| PRCT | 1.1 | — | 2.9 | — | -7.4% | +23% | -34% | -77% |
| AORT | 1.1 | — | 3.0 | 31.5 | -0.8% | +16% | 4% | 2% |
| IRMD | 1.1 | 47.9 | 12.0 | 35.6 | 2.2% | +11% | 32% | 51% |
| CBLL | 1.0 | — | 9.1 | — | -5.3% | +32% | -69% | -52% |
| SIBN | 1.0 | — | 4.5 | — | -0.5% | +15% | -8% | -10% |
| QDEL | 0.9 | — | 1.4 | — | — | -2% | -31% | -17% |
| IART | 0.9 | — | 1.5 | 10.8 | 9.3% | +0.8% | 4% | 2% |
| Median of these 10 | 37.3 | 2.3 | 14.0 | -0.5% | +8% | -6% | -9% |
; EV/Sales 2.5 vs. 2.3.
Growth vs. price
each dot a company · hover or tap for valuesBioventus Inc. — questions
- What is Bioventus Inc.'s market cap?
- $1.3B.
- What is Bioventus Inc.'s price-to-sales ratio?
- 2.2.
Every figure on this page comes from Bioventus Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.